The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Trading Statement

25 Mar 2019 07:00

RNS Number : 7798T
Standard Life Private Eqty Trst PLC
25 March 2019
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 31 December 2018

 

· The net asset value ("NAV") per ordinary share of Standard Life Private Equity Trust PLC ("the Company") decreased by 0.5% to 428.2 pence for the quarter ended 31 December 2018

· Realised gains and income on the unquoted portfolio during the quarter ended 31 December 2018 totalled £11.3 million (1.7% of NAV). The unrealised loss on a constant exchange rate basis was 11.4 million (1.7% of NAV). In addition, there were unrealised foreign exchange gains of £4.9 million (0.7% of NAV)

· The final quarter dividend for the financial year ending 30 September 2018 of 3.1 pence per share was paid on 25 January 2019

· 99.0% by value of the portfolio was valued by the respective underlying managers at 31 December 2018

· NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018

· Outstanding commitments were £385.6 million at 31 December 2018

· Resources available for investment were £95.6 million at 31 December 2018

 

For the quarter ended 31 December 2018, the Company's NAV decreased by 0.5% to 428.2 pence per share, from 430.2 pence per share at 30 September 2018. At 31 December 2018, the Company's net assets were £658.3 million (30 September 2018 - £661.4 million). NAV total return was 0.1% for the three months from 1 October 2018 to 31 December 2018.

 

The closing value of the Company's unquoted portfolio, which, included 55 private equity fund interests, was £562.1 million at 31 December 2018 (30 September 2018 - £574.7 million and 55 private equity fund interests). The total unrealised loss on the unquoted portfolio for the quarter ended 31 December 2018 was £6.5 million, comprising £11.4 million of unrealised loss on a constant exchange rate basis and £4.9 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) both fell by 11% during the quarter. The unrealised foreign exchange gains were driven by the euro and the US Dollar appreciating by 0.8% and 2.3% respectively, relative to sterling over the quarter.

 

During the quarter ended 31 December 2018, the unquoted portfolio generated £28.7 million of distributions (quarter ended 30 September 2018 - £24.4 million). The Company funded £11.4 million of drawdowns (quarter ended 30 September 2018 - £31.0 million) into the unquoted portfolio. The distributions received during the quarter generated £11.3 million of net realised gains and income. The net realised gains and income include the realised loss on written-off investments which were previously already recognised within unrealised losses. Excluding the realised loss on written-off investments, the net realised gains and income was £17.1 million. This was equivalent to a return of 2.5 times the acquisition cost of the realised investments.

 

The Company made one new fund commitment of €30.0 million to Triton V. The Company had total outstanding commitments to its 55 private equity fund interests of £385.6 million at 31 December 2018 (30 September 2018 - £369.3 million to 55 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 31 December 2018, the Company had resources available for investment of £95.6 million (30 September 2018 - resources available for investment of £86.5 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

 

2. Activity since 31 December 2018

 

On 25 January 2019, the Company paid the final dividend for the year ended 30 September 2018 of 3.1 pence per ordinary share. The cost of the final dividend was £4.8m. In addition, the Company declared a first quarter dividend for the year ending 30 September 2019 of 3.2 pence per share, to be paid on 26 April 2019, to shareholders on the Company's share register as at 22 March 2019. The ex-dividend date is 21 March 2019.

 

During the period from the 1 January 2019 to the 8 March 2019 the Company funded £14.2 million of drawdowns and received £11.8 million of distributions.

 

A new commitment of €35m was made to Altor V on 6 February 2019, and a new co- investment commitment of €6m was made to Mademoiselle Desserts, alongside IK Investment Partners, on 15 February 2019.

 

At 8 March 2019, the Company had resources available for investment of £90.6 million. The Company also had total outstanding commitments of £394.0 million.

 

The Company's estimated NAV at 28 February 2019 is also being announced today. It is anticipated that the Company will release its results for the six months ending 31 March 2019 on or around 19 June 2019.

 

For further information please contact:-

 

Merrick McKay at SL Capital Partners LLP (0131 245 2345)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc and Phoenix Group Holdings.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTELLFLKXFZBBQ
Date   Source Headline
17th Jan 20207:00 amRNSDoc re. Annual Report
15th Jan 20207:00 amRNSMonth End Net Asset Value(s)
14th Jan 20204:18 pmRNSDirector/PDMR Shareholding
9th Jan 20207:00 amRNSAnnual Financial Report
6th Jan 202011:31 amRNSQuarterly Disclosure
13th Dec 20197:00 amRNSMonth End Net Asset Value(s)
12th Dec 20197:00 amRNSFourth Quarter Dividend Declaration
14th Nov 20197:00 amRNSMonth end Net Asset Value(s)
12th Nov 20194:22 pmRNSDirector/PDMR Shareholding
1st Nov 20192:45 pmRNSDirector/PDMR Shareholding
14th Oct 201911:00 amRNSMonth End Net Asset Value(s)
3rd Oct 201911:05 amRNSQuarterly Disclosure
27th Sep 20192:50 pmRNSEstimated Net Asset Value at 31 August 2019
27th Sep 20192:44 pmRNSQuarterly Trading Statement
12th Sep 20197:00 amRNSDeclaration of Third Quarter Dividend
29th Aug 20197:05 amRNSCompany Secretary Change
14th Aug 20192:24 pmRNSDirector/PDMR Shareholding
14th Aug 20197:00 amRNSEstimated Net Asset Value at 31 July 2019
5th Aug 201911:10 amRNSDirector Declaration
30th Jul 201910:53 amRNSDirector/PDMR Shareholding
12th Jul 20197:00 amRNSEstimated Net Asset Value at 30 June 2019
2nd Jul 20191:11 pmRNSQuarterly Disclosure
19th Jun 20197:06 amRNSEstimated Net Asset Value at 31 May 2019
19th Jun 20197:00 amRNSHalf-year Report
13th Jun 20197:00 amRNSDividend Declaration
29th May 201911:30 amRNSUpdate research from QuotedData
15th May 20197:00 amRNSEstimated Net Asset Value as at 30 April 2019
2nd May 201911:02 amRNSDirector/PDMR Shareholding
12th Apr 20197:00 amRNSEstimated Net Asset Value at 31 March 2019
2nd Apr 20193:55 pmRNSQuarterly Disclosure
1st Apr 201910:08 amRNSChange of Depositary
25th Mar 20197:00 amRNSEstimated net asset value as at 28 February 2019
25th Mar 20197:00 amRNSQuarterly Trading Statement
14th Mar 201911:31 amRNSEdison issues review on Standard Life Private
14th Mar 20197:00 amRNSDividend Declaration
14th Feb 20197:00 amRNSEstimated Net Asset Value at 31 January 2019
29th Jan 20194:27 pmRNSDirector/PDMR Shareholding
22nd Jan 20192:17 pmRNSResult of AGM
15th Jan 20197:00 amRNSEstimated Net Asset Value at 31 December 2018
3rd Jan 20192:17 pmRNSQuarterly Disclosure
31st Dec 201811:18 amRNSDividend Declaration
27th Dec 201811:03 amRNSDirector/PDMR Shareholding
18th Dec 201811:27 amRNS2018 Annual Report and AGM
14th Dec 20187:00 amRNSEstimated Net Asset Value at 30 November 2018
12th Dec 20187:00 amRNSAnnual Financial Report
7th Dec 20184:05 pmRNSDirectorate Change
14th Nov 20187:00 amRNSEstimated Net Asset Value at 31 October 2018
6th Nov 20183:27 pmRNSDirector/PDMR Shareholding
2nd Nov 201812:02 pmRNSDirector/PDMR Shareholding
12th Oct 20187:00 amRNSEstimated Net Asset Value at 30 September 2018

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.